338 related articles for article (PubMed ID: 9413180)
1. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
[TBL] [Abstract][Full Text] [Related]
2. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
3. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
4. Chemical structure and tumor type specificity of "half-mustard type" phenothiazines.
Motohashi N; Kurihara T; Sakagami H; Szabo D; Csuri K; Molnár J
Anticancer Res; 1999; 19(3A):1859-64. PubMed ID: 10470128
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of phenothiazine-related compounds.
Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
[TBL] [Abstract][Full Text] [Related]
6. Electronic structure and cytotoxic activity of "half-mustard type" phenothiazines by MM3 and PM3 methods.
Kurihara T; Nojima K; Sakagami H; Motohashi N; Molnár J
Anticancer Res; 1999; 19(5B):3895-9. PubMed ID: 10628328
[TBL] [Abstract][Full Text] [Related]
7. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Hu K; Yao X
Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
[TBL] [Abstract][Full Text] [Related]
8. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
Ford JM; Prozialeck WC; Hait WN
Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
[TBL] [Abstract][Full Text] [Related]
9. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
[TBL] [Abstract][Full Text] [Related]
10. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives.
Motohashi N; Sakagami H; Kamata K; Yamamoto Y
Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929
[TBL] [Abstract][Full Text] [Related]
13. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
Marx KA; O'Neil P; Hoffman P; Ujwal ML
J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
[TBL] [Abstract][Full Text] [Related]
15. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
[TBL] [Abstract][Full Text] [Related]
16. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
17. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
18. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
19. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
Zhukova OS; Dobrynin IaV
Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antiproliferative effect of N-(alkyladamantyl)phthalimides in vitro.
Horvat M; Uzelac L; Marjanović M; Cindro N; Franković O; Mlinarić-Majerski K; Kralj M; Basarić N
Chem Biol Drug Des; 2012 Apr; 79(4):497-506. PubMed ID: 22176512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
